TMS and The Future of Psychiatry with Dr. Owen Muir | Psychofarm Podcast

Dr. Owen Muir discusses how accelerated transcranial magnetic stimulation protocols are transforming the treatment of depression and OCD.

Dr. Owen Muir discusses transcranial magnetic stimulation (TMS), detailing how accelerated TMS protocols are transforming depression, OCD, and mental health in general. With robust clinical experience and data, Dr. Muir highlights TMS as a cutting-edge, noninvasive therapy that will redefine modern psychiatry and mental health care. 💡Anti-depressant Course: psycho.farm/antidepressant-course 📖 PsychoFarm's Treating Depression Book: a.co/d/3M0uFui ================ Follow PsychoFarm: 🔴SUBSCRIBE ► youtube.com/c/Psychofarm?sub_confirmation=1 🧠Mental Health Resources: psycho.farm/services-4 ➡️Instagram: instagram.com/thepsychofarm/ ➡️Tiktok: tiktok.com/@thepsychofarm ➡️Twitter: twitter.com/ThePsychoFARM ================ In this expansive podcast, Dr. Owen Muir, an authority in transcranial magnetic stimulation (TMS), leads an in-depth discussion on how modern neuromodulation is revolutionizing psychiatric treatment. The conversation opens by contrasting traditional pharmaceutical approaches with TMS, a noninvasive brain stimulation technique that uses precise magnetic fields to induce electrical currents, recalibrate neural synchronization, and enhance neuroplasticity. Listeners are introduced to the science behind TMS, which mimics the brain’s natural communication by targeting specific neural circuits that underlie depression, obsessive-compulsive disorder (OCD), bipolar disorder, and even emerging applications in eating disorders and post-traumatic stress disorder (PTSD). Dr. Muir elaborates on how TMS evolved from early research in the 1980s in the UK to become an FDA-approved treatment that now benefits patients with treatment-resistant depression. Through advanced imaging and brain mapping techniques, practitioners can accurately locate the optimal stimulation site, often in the left frontal cortex, to ensure that the induced electrical current is delivered with maximum efficacy. This targeted approach not only supports the modulation of mood disorders but also underscores TMS’s potential in reestablishing normal neural connectivity and cognitive function. A significant portion of the podcast is dedicated to discussing accelerated TMS protocols. Unlike traditional treatment regimens that spread sessions over several weeks, accelerated TMS involves multiple sessions in a single day, offering a faster path to remission. The discussion highlights that with careful calibration of stimulation intensity—determined by a patient’s motor threshold, and precision coil placement, accelerated TMS can effectively “reset” neural rhythms in a way that conventional pharmacotherapy may not. This rapid therapeutic effect is attributed to TMS’s ability to induce neural synchronization, essentially “tuning” the brain much like adjusting the tempo in a complex musical composition. Moreover, the podcast compares TMS with other neuromodulatory techniques such as EEG neurofeedback and t